NOVOGEN LIMITED Chart calendar Novogen Limited
3a6a77a8cc46c66898d8c843be710e2.PtS-0MjBkJuzc2dtsR0JjBYXShF9yL7_2N9hVoTf2Zs.CKH3pZue-PDpJCok_1JbzWB4ECkoofi8nYhUF8HmjeMMnd-9h7bH34U8DA~898eac4075624a6e721e4036a8a709ba
Upcoming events on Novogen Limited
Past events on Novogen Limited
| 2024-04-09 05:50 pm | American Association for Cancer Research Meeting - Abstract No 6565 |
| 2024-04-08 12:00 pm | American Association for Cancer Research Meeting - Abstract No CT088 |
| 2024-04-07 04:30 pm | American Association for Cancer Research Meeting - Abstract No 1059 |
| 2023-11-29 06:00 pm | Annual General Meeting |
| 2023-11-18 | Society for Neuro Oncology Meeting - PNOC022 A Combination Therapy |
| 2023-11-17 07:00 am | Society for Neuro Oncology Meeting |
| 2023-11-16 | Society for Neuro Oncology Meeting - Combining ONC201 and Paxalisib |
| 2023-10-30 06:52 pm | September 2023 Sales and Revenue Release - Activities Report |
| 2023-10-20 | European Society for Medical Oncology Congress |
| 2023-09-12 12:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-31 03:21 am | Q4 2023 Earnings Release |
Annual results
| Fiscal Period | June | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 1,47 3,07 -52.33% | 1,00 2,75 -63.82% | 15,2 18,7 -18.81% | 0,03 0,27 -90.14% | 0,02 0,01 100.96% |
|
EBITDA Million AUD | Released Forecast Spread | -7,61 -10,5 27.33% | -11,0 -8,70 -26.88% | 0,00 0,00 - | -23,1 -24,1 4.33% | 0,00 0,00 - |
|
EBIT Million AUD | Released Forecast Spread | -10,7 -11,9 10.6% | -12,8 -9,95 -28.96% | -6,38 -7,40 13.81% | -25,0 -25,6 2.23% | -24,1 -25,9 6.68% |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -10,6 -11,9 10.99% | -12,8 -9,95 -28.3% | -8,91 -7,20 -23.7% | -25,0 -27,0 7.46% | -20,7 -27,2 23.76% |
|
Net income Million AUD | Released Forecast Spread | -10,3 -11,9 13.51% | -12,5 -9,90 -25.93% | -8,42 -7,20 -16.97% | -24,6 -27,0 8.82% | -20,5 -25,8 20.68% |
|
EPS AUD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -1,86 -1,15 -62.25% | 0,00 0,00 - |
| Announcement Date | 28/08/19 | 26/08/20 | 25/08/21 | 28/08/22 | 31/08/23 |
Quarterly results
| Fiscal Period | June | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 0,00 | 0,37 3,40 -89.14% | 0,03 0,61 -94.75% | 15,2 18,7 -18.82% | 0,03 0,00 - | 0,00 0,34 -99.97% | 0,00 0,00 -87.27% | 0,02 0,01 99.74% |
|
EBIT Million AUD | Released Forecast Spread | -6,77 -4,00 -69.22% | -6,51 -7,70 15.38% | 0,06 -1,00 106% | -13,3 -9,30 -42.63% | -11,7 -11,8 0.86% | -10,5 -12,2 13.92% | ||
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -11,7 -13,6 14.14% | |||||||
|
Net income Million AUD | Released Forecast Spread | -5,88 | -11,6 -13,6 14.52% | -13,6 | -6,88 -10,8 36.41% | ||||
|
EPS AUD | Released Forecast Spread | -0,87 -0,10 -774.6% | |||||||
| Announcement Date | 19/02/20 | 26/08/20 | 24/02/21 | 25/08/21 | 23/02/22 | 28/08/22 | 28/02/23 | 31/08/23 |
| Today 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| Today 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| Today 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-05-01 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | INTELLIA THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | GALAPAGOS NV: Q1 2024 Earnings Release |
| 2024-05-02 06:30 am | MODERNA, INC.: Q1 2024 Earnings Release |
